PCOS is still treated as per symptom e.g. 1) Obesity/ overweight,
b) Hyperinsulinemic C) Oligomenorrheic D) hyperandrogenic. E) Fertility issues.
In this particular case Drug selection is based on evidence based on Lab
reports/including selection of ovulogens? Can it be based on phenotypic
features? Or both? Hyperandrogeniaemia
and or hyperinsulinaemia,
|
Phenotypes |
Of |
PCOS |
USG |
|
|
|
|
Type A |
Testosterone + |
Chr Anovulation. |
PCOS morphology. |
Cypro containg OCP OCP/DSG containg pills |
Prevalence of Type I 65% of all PCO |
Metabolic syn later is 38% |
|
Type B |
-do- |
-do- |
no |
|
Prevalence of Type II: 23% |
10% |
|
Type C |
do |
no |
yes |
|
1% |
3% |
|
Type D |
No |
yes |
Yes. |
|
11% |
50% |
|
|
|
|
|
|
|
|
No comments:
Post a Comment